Development of a Potent Cyclic Peptide Inhibitor of the nNOS/PSD-95 Interaction-Reference-Cited by-同舟云学术

Development of a Potent Cyclic Peptide Inhibitor of the nNOS/PSD-95 Interaction

Published:2022-12-29 Issue:1 Volume:66 Page:976-990
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Balboa Javier R.¹²,Essig Dominik J.¹²,Ma Sana²,Karer Nichlas²,Clemmensen Louise S.²,Pedersen Søren W.²,Joerger Andreas C.³⁴^ORCID,Knapp Stefan³⁴^ORCID,Østergaard Søren¹^ORCID,Strømgaard Kristian²^ORCID

Affiliation:

1. Novo Nordisk A/S, Research Chemistry 3, Novo Nordisk Park, 2760 Måløv, Denmark

2. Center for Biopharmaceuticals, Department of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark

3. Institute of Pharmaceutical Chemistry, Goethe University, Max-von-Laue Str. 9, 60438 Frankfurt am Main, Germany

4. Structural Genomics Consortium (SGC), Buchmann Institute for Molecular Life Sciences (BMLS), Max-von-Laue-Str. 15, 60438 Frankfurt am Main, Germany

Funder

Bayer

Merck KGaA

Genentech

Takeda Pharmaceutical Company

Deutsche Forschungsgemeinschaft

Pfizer

H2020 Marie Sklodowska-Curie Actions

Bristol-Myers Squibb

Genome Canada

Boehringer Ingelheim

Janssen